Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

RTTNews | 785 gün önce
Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

(RTTNews) - Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Tuesday that the Company's Board of Directors has appointed Eliot Richard Forster to serve on the Board of Directors as its Chairman, effective as of September 14, 2023.

In addition to Forster's appointment as Chairman and an independent director, he was also appointed to serve on the Company's Nominating Committee. Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.

Forster currently serves as the Non-Executive Chairman of Avacta Group PLC (AVCT), as a Non-Executive Director of Immatics NV (IMTX) and as the Non-Executive Chairman of Ochre Bio, Inc., a private biotechnology company.

Forster served as the Chief Executive Officer of F-Star Therapeutics Ltd., a clinical-stage bispecific antibodies company, until its March 2023 sale to inovoX Ltd. Prior to that, he served as CEO of Immunocure Ltd., CEO of Creabilis SA and President and CEO of Solace Pharmaceuticals Inc., each of which was a privately-held life science company.

Earlier in his career, he held positions at Pfizer Global Research & Development and Glaxo/GlaxoWellcome.

Etiketler: PLX
read more
Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending marketing authorization for PRX-102 (pegunigalsidase alfa), the first and only pegylated enzyme for the treatment of adult patients with Fabry disease.
RTTNews | 984 gün önce
European Economic News Preview: German Factory Orders Data Due

European Economic News Preview: German Factory Orders Data Due

Factory orders from Germany and final purchasing managers' survey results from the euro area are due on Wednesday, headlining a busy day for the European economic news. At 2.00 am ET, Destatis is scheduled to issue Germany's factory orders data. Orders are forecast to grow 0.9 percent on a monthly basis in September, a turnaround from the 0.8 percent drop in August.
RTTNews | 1s 30 dakika önce
China Services Activity Expands On New Business

China Services Activity Expands On New Business

China's service sector continued to grow in October as new business growth accelerated despite a fall in export sales, survey data published by S&P Global showed on Wednesday. The headline RatingDog service Purchasing Managers' Index fell to 52.6 in October from 52.9 in September. Although the growth was the softest in three months, the sector extended the current period of expansion.
RTTNews | 2s 17 dakika önce
Australian Market Extends Early Losses In Mid-market

Australian Market Extends Early Losses In Mid-market

The Australian stock market is extending its early losses in mid-market moves on Wednesday, adding to the losses in the previous session, with the benchmark S&P/ASX 200 falling well below the 8,800 level, following the broadly negative cues from Wall Street overnight, dragged by tumbling mining, energy and technology stocks.
RTTNews | 4s 38 dakika önce
Asian Markets A Sea Of Red

Asian Markets A Sea Of Red

Asian stock markets are a sea of red on Wednesday, following the broadly negative cues from Wall Street overnight, dragged by the benchmark indexes in Japan and South Korea which are plunging 4 to 5 percent each on concerns over stretched valuations as global tech stocks tumble on fears that an AI bubble is about to burst. Asian markets closed mostly lower on Tuesday.
RTTNews | 4s 57 dakika önce